{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:00:48Z","timestamp":1765609248907},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2003,1]]},"DOI":"10.1016\/s1590-8658(02)00006-3","type":"journal-article","created":{"date-parts":[[2003,4,30]],"date-time":"2003-04-30T18:23:46Z","timestamp":1051727026000},"page":"20-23","source":"Crossref","is-referenced-by-count":19,"title":["Triple therapy for 7 days vs. triple therapy for 7 days plus omeprazole for 21 days in treatment of active duodenal ulcer with Helicobacter pylori infection"],"prefix":"10.1016","volume":"35","author":[{"given":"L","family":"Marzio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Cellini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Angelucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S1590-8658(02)00006-3_BIB1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/gut.41.1.8","article-title":"Current European concepts in management of Helicobacter pylori infection. The Maastricht Consensus report","volume":"41","year":"1997","journal-title":"Gut"},{"key":"10.1016\/S1590-8658(02)00006-3_BIB2","doi-asserted-by":"crossref","unstructured":"Consensus Conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters. Committee of the American College of Gastroenterology. J Am Med Assoc 1996;275:622\u20139.","DOI":"10.1001\/jama.1996.03530320046033"},{"key":"10.1016\/S1590-8658(02)00006-3_BIB3","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/0016-5085(92)90004-I","article-title":"Helicobacter pylori infection and gastric function in patients with chronic idiopathic dyspepsia","volume":"103","author":"Tucci","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/S1590-8658(02)00006-3_BIB4","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1590-8658(00)80395-3","article-title":"Cure of Helicobacter pylori-positive active duodenal ulcer patients: a double blind, multicentre, 12-month study comparing a two-week dual vs. one-week triple therapy","volume":"32","author":"Di Mario","year":"2000","journal-title":"Digest Liver Dis"},{"key":"10.1016\/S1590-8658(02)00006-3_BIB5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1046\/j.1365-2036.1999.00471.x","article-title":"The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy","volume":"13","author":"Zanten","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/S1590-8658(02)00006-3_BIB6","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1046\/j.1523-5378.1999.09041.x","article-title":"High dose omeprazole plus amoxicillin and azithromycin in eradication of Helicobacter pylori in duodenal ulcers","volume":"4","author":"Vcev","year":"1999","journal-title":"Helicobacter"},{"key":"10.1016\/S1590-8658(02)00006-3_BIB7","first-page":"2161","article-title":"Acid suppression with ranitidine plus oral triple therapy improves ulcer healing but not Helicobacter pylori eradication","volume":"45","author":"Magalhaes","year":"1998","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/S1590-8658(02)00006-3_BIB8","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1111\/j.1572-0241.1998.00602.x","article-title":"Twice daily, 10-day triple therapy with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in duodenal ulcer disease: results of three multicenter, double blind, United States trial","volume":"93","author":"Laine","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/S1590-8658(02)00006-3_BIB9","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1046\/j.1365-2036.2000.00870.x","article-title":"Role of antimicrobial susceptibility testing on efficacy of triple therapy in Helicobacter pylori eradication","volume":"14","author":"Toracchio","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/S1590-8658(02)00006-3_BIB10","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1046\/j.1365-2036.1998.00362.x","article-title":"Incidence of duodenal ulcer healing after 1 week of proton pump inhibitor triple therapy for eradication of Helicobacter pylori. The Lansoprazole Helicobacter Study Group","volume":"12","author":"Harris","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/S1590-8658(02)00006-3_BIB11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1365-2036.2000.00708.x","article-title":"Seven-day triple therapy with ranitidine bismuth citrate or omeprazole and two antibiotics for eradication of Heliocbacter pylori in duodenal ulcer: a multicentre, randomized, single-blind study","volume":"14","author":"Spinzi","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/S1590-8658(02)00006-3_BIB12","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1097\/00042737-200112000-00009","article-title":"One week treatment with esomeprazole-based triple therapy eradicates Helicobacter pylori and heals patients with duodenal ulcer disease","volume":"13","author":"Tulassay","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/S1590-8658(02)00006-3_BIB13","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1046\/j.1365-2036.2001.00999.x","article-title":"Three-day lansoprazole quadruple therapy for Helicobacter pylori positive duodenal ulcers: a randomized controlled study","volume":"15","author":"Wong","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/S1590-8658(02)00006-3_BIB14","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF01537225","article-title":"Omeprazole versus placebo in duodenal ulcer healing. The United States experience","volume":"35","author":"Graham","year":"1990","journal-title":"Dig Dis Sci"},{"key":"10.1016\/S1590-8658(02)00006-3_BIB15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/gut.35.1.15","article-title":"One week\u2019s anti-Helicobacter pylori treatment for duodenal ulcer","volume":"35","author":"Logan","year":"1994","journal-title":"Gut"},{"key":"10.1016\/S1590-8658(02)00006-3_BIB16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1056\/NEJM199501193320302","article-title":"Antibacterial treatment of gastric ulcers associated with Helicobacter pylori","volume":"332","author":"Sung","year":"1995","journal-title":"N Engl J Med"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865802000063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865802000063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T15:28:23Z","timestamp":1553182103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865802000063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["S1590865802000063"],"URL":"https:\/\/doi.org\/10.1016\/s1590-8658(02)00006-3","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2003,1]]}}}